These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1121004)

  • 1. Studies on cyclophosphamide metabolites and their related compounds. 2. Preparation of an active species of cyclophosphamide and related compounds.
    Takamizawa A; Matsumoto S; Iwata T; Tochino Y; Katagiri K; Yamaguchi K
    J Med Chem; 1975 Apr; 18(4):376-83. PubMed ID: 1121004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isophosphoramide mustard, a metabolite of ifosfamide with activity against murine tumours comparable to cyclophosphamide.
    Struck RF; Dykes DJ; Corbett TH; Suling WJ; Trader MW
    Br J Cancer; 1983 Jan; 47(1):15-26. PubMed ID: 6821629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antitumor activity of cyclophosphamide analogs. 1. Benzo annulated cyclophosphamide and related systems.
    Ludeman SM; Zon G
    J Med Chem; 1975 Dec; 18(12):1251-3. PubMed ID: 1195278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclophosphamide. Complete inhibition of murine leukemia L1210 in vivo by a Fenton oxidation product.
    Struck RF; Thorpe MC; Coburn WC; Laster WR
    J Am Chem Soc; 1974 Jan; 96(1):313-5. PubMed ID: 4810573
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative pharmacologic study in vitro and in vivo with cyclophosphamide (NSC-26271), cyclophosphamide metabolites, and plain nitrogen mustard compounds.
    Brock N
    Cancer Treat Rep; 1976 Apr; 60(4):301-8. PubMed ID: 1277205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antitumor activity of 6-trifluoromethylcyclophosphamide and related compounds.
    Farmer PB; Cox PJ
    J Med Chem; 1975 Nov; 18(11):1106-10. PubMed ID: 1177256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two stable Fenton oxidation products of cyclophosphamide (NSC-26271) as precursors of 4-hydroxycyclophosphamide (NSC-196562) under physiologic conditions.
    Benckhuysen C; van der Steen J; Spanjersberg EJ
    Cancer Treat Rep; 1976 Apr; 60(4):369-72. PubMed ID: 945125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of deuterium-labeled analogs of cyclophosphamide and its metabolites.
    Griggs LJ; Jarman M
    J Med Chem; 1975 Nov; 18(11):1102-6. PubMed ID: 1177255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antitumor evaluation of 4-ethoxycarbonyl cyclophosphamide analogs.
    Foster EL
    J Pharm Sci; 1978 May; 67(5):709-10. PubMed ID: 641817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereochemistry, metabolism, and antitumor activity of 4-hydroperoxyisophosphamide (NSC-227114) and its stereoisomer.
    Takamizawa A; Iwata T; Yamaguchi K; Shiratori O; Harada M
    Cancer Treat Rep; 1976 Apr; 60(4):361-8. PubMed ID: 1277212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on 4-hydroperoxycyclophosphamide (NSC-181815): a simple preparation method and its application for the synthesis of a new class of "activated" sulfur-containing cyclophosphamide (NSC-26271) derivatives.
    Peter G; Wagner T; Hohorst HJ
    Cancer Treat Rep; 1976 Apr; 60(4):429-35. PubMed ID: 1277218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antitumor activity of two ifosfamide analogs with a five-membered ring.
    Kutscher B; Niemeyer U; Engel J; Kleemann A; Hilgard P; Pohl J; Scheffler G
    Arzneimittelforschung; 1995 Mar; 45(3):323-6. PubMed ID: 7741794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacological studies with alkylsulfonyloxyalkyl substituted and chloroethyl substituted oxazaphosphorine-2-oxides. 2. Pharmacological characterization of 2-alkylsulfonyl-oxyalkylamino-oxazaphosphorine-2-oxides including immunological reaction].
    Arzneimittelforschung; 1974 Aug; 24(8):1149-60. PubMed ID: 4371545
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacological studies with alkylsulfonyloxyalkyl substituted and chloroethyl substituted oxazaphosphorine-2-oxides. 1. Communication: relationship between chemical structure and pharmacological action.
    Brock N; Kuhlmann J
    Arzneimittelforschung; 1974 Aug; 24(8):1139-49. PubMed ID: 4371234
    [No Abstract]   [Full Text] [Related]  

  • 15. Cross-linking of DNA in L1210 cells and nuclei treated with cyclophosphamide and phosphoramide mustard.
    Surya YA; Rosenfeld JM; Hillcoat BL
    Cancer Treat Rep; 1978 Jan; 62(1):23-9. PubMed ID: 564237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologic activity of two derivatives and six possible metabolites of cyclophosphamide (NSC-26271).
    Lelieveld P; van Putten LM
    Cancer Treat Rep; 1976 Apr; 60(4):373-9. PubMed ID: 1064468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mass spectrometric characterization of activated N-(2-chloroethyl)amino oxazaphosphorine derivative.
    Przybylski M; Ringsdorf H; Lenssen U; Peter G; Voelcker G; Wagner T; Hohorst HJ
    Biomed Mass Spectrom; 1977 Aug; 4(4):209-15. PubMed ID: 912018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The problem of oncostatic specificity of cyclophosphamide (NSC-26271): Studies on reactions that control the alkylating and cytotoxic activity.
    Hohorst HJ; Draeger U; Peter G; Voelcker G
    Cancer Treat Rep; 1976 Apr; 60(4):309-15. PubMed ID: 1277206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ifosfamide in experimental tumor systems.
    Goldin A
    Semin Oncol; 1982 Dec; 9(4 Suppl 1):14-23. PubMed ID: 6761864
    [No Abstract]   [Full Text] [Related]  

  • 20. [Selective effect of N,N-bis-(2-chloroethyl)-N1,O-propylenephosphoric acid ester-diamide and analogues on the CAM-tumor system].
    Rauen HM; Norpoth K; Sunder-Plassmann A
    Arzneimittelforschung; 1968 Jan; 18(1):105-9. PubMed ID: 5754936
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.